These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 3264363

  • 1. Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human bone marrow cells.
    Bhalla K, Birkhofer M, Arlin Z, Grant S, Lutzky J, Graham G.
    Leukemia; 1988 Dec; 2(12):810-3. PubMed ID: 3264363
    [Abstract] [Full Text] [Related]

  • 2. Recombinant GM-CSF modulates the metabolism of cytosine arabinoside in leukemic cells in bone marrow.
    Tanaka M.
    Leuk Res; 1993 Jul; 17(7):585-92. PubMed ID: 8326741
    [Abstract] [Full Text] [Related]

  • 3. Differential effect of interleukin 3 on the metabolism of high-dose cytosine arabinoside in normal versus leukemic human bone marrow cells.
    Bhalla K, Birkhofer M, Arlin Z, Grant S, Lutzky J, Safah H, Graham G.
    Exp Hematol; 1991 Aug; 19(7):669-73. PubMed ID: 1893953
    [Abstract] [Full Text] [Related]

  • 4. Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cells.
    Grant S, Traylor R, Bhalla K, McCrady C, Pettit GR.
    Leukemia; 1992 May; 6(5):432-9. PubMed ID: 1593908
    [Abstract] [Full Text] [Related]

  • 5. The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells.
    Bhalla K, Birkhofer M, Grant S, Graham G.
    Exp Hematol; 1989 Jan; 17(1):17-20. PubMed ID: 2783247
    [Abstract] [Full Text] [Related]

  • 6. Effect of the protein kinase C activating agent bryostatin 1 on the clonogenic response of leukemic blast progenitors to recombinant granulocyte-macrophage colony-stimulating factor.
    Grant S, Pettit GR, Howe C, McCrady C.
    Leukemia; 1991 May; 5(5):392-8. PubMed ID: 2033960
    [Abstract] [Full Text] [Related]

  • 7. Effect of recombinant GM-CSF and recombinant G-CSF on colony formation of blast progenitors in acute myeloblastic leukemia.
    Motoji T, Takanashi M, Fuchinoue M, Masuda M, Oshimi K, Mizoguchi H.
    Exp Hematol; 1989 Jan; 17(1):56-60. PubMed ID: 2783249
    [Abstract] [Full Text] [Related]

  • 8. Effects of rhGM-CSF on intracellular ara-C pharmacology in vitro in acute myelocytic leukemia: comparability with drug-induced humoral stimulatory activity.
    Karp JE, Burke PJ, Donehower RC.
    Leukemia; 1990 Aug; 4(8):553-6. PubMed ID: 2201833
    [Abstract] [Full Text] [Related]

  • 9. GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cells.
    De Witte T, Muus P, Haanen C, Van der Lely N, Koekman E, Van der Locht A, Blankenborg G, Wessels J.
    Behring Inst Mitt; 1988 Aug; (83):301-7. PubMed ID: 3071344
    [Abstract] [Full Text] [Related]

  • 10. Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells.
    Van Der Lely N, De Witte T, Muus P, Raymakers R, Preijers F, Haanen C.
    Exp Hematol; 1991 May; 19(4):267-72. PubMed ID: 2055291
    [Abstract] [Full Text] [Related]

  • 11. Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia.
    Cannistra SA, Groshek P, Griffin JD.
    Leukemia; 1989 May; 3(5):328-34. PubMed ID: 2654494
    [Abstract] [Full Text] [Related]

  • 12. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
    te Boekhorst PA, Löwenberg B, Vlastuin M, Sonneveld P.
    Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
    [Abstract] [Full Text] [Related]

  • 13. Effect of deoxycytidine on the metabolism and cytotoxicity of 5-aza-2'-deoxycytidine and arabinosyl 5-azacytosine in normal and leukemic human myeloid progenitor cells.
    Bhalla K, Cole J, MacLaughlin W, Arlin Z, Baker M, Graham G, Grant S.
    Leukemia; 1987 Dec; 1(12):814-9. PubMed ID: 2447450
    [Abstract] [Full Text] [Related]

  • 14. Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemic blast cells from ara-C toxicity.
    Koistinen P, Wang C, Curtis JE, McCulloch EA.
    Leukemia; 1991 Sep; 5(9):789-95. PubMed ID: 1719308
    [Abstract] [Full Text] [Related]

  • 15. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH, Talpaz M, Deisseroth AB, Estrov Z.
    Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
    [Abstract] [Full Text] [Related]

  • 16. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM, Gulati SC, Strife A, Lambek C, Perez A, Clarkson BD.
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [Abstract] [Full Text] [Related]

  • 17. Blast cell proliferative activity and sensitivity to GM-CSF in vitro are associated with early response to TAD-9 induction therapy in acute myeloid leukemia.
    Jahns-Streubel G, Reuter C, Unterhalt M, Schleyer E, Wörmann B, Büchner T, Hiddemann W.
    Leukemia; 1995 Nov; 9(11):1857-63. PubMed ID: 7475275
    [Abstract] [Full Text] [Related]

  • 18. Effects of rGM-CSF on leukemia cell proliferation and on the incorporation of cytosine arabinoside into DNA.
    Gao XZ, Yin MY, Wang ZQ, Raza A, Preisler HD.
    Cell Biochem Funct; 1991 Jul; 9(3):155-61. PubMed ID: 1752023
    [Abstract] [Full Text] [Related]

  • 19. Differential effect of GM-CSF pretreatment on intracellular Ara-C metabolism in normal bone marrow mononuclear cells vs acute myeloid leukemia (AML) blasts.
    Reuter C, Schleyer E, Rolf C, Wörmann B, Büchner T, Hiddemann W.
    Leukemia; 1997 Apr; 11(4):561-71. PubMed ID: 9096697
    [Abstract] [Full Text] [Related]

  • 20. Effect of bryostatin 1 on the in vitro radioprotective capacity of recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) toward committed human myeloid progenitor cells (CFU-GM).
    Grant S, Pettit GR, McCrady C.
    Exp Hematol; 1992 Jan; 20(1):34-42. PubMed ID: 1374343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.